P. Rousseau, J. L. Habrand, D. Sarrazin, C. Kalifa, M. J. Terrier-lacombe et al., Treatment of intracranial ependymomas of children: review of a 15-year experience, Int J Radiat Oncol Biol Phys, vol.28, pp.381-387, 1994.

G. Perilongo, M. Massimino, G. Sotti, T. Belfontali, L. Masiero et al., Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian pediatric neuro-oncology group, Med Pediatr Onco, vol.29, pp.79-85, 1997.

S. J. Mørk, A. C. Løken, and . Ependymoma, A follow-up study of 101 cases, Cancer, vol.40, pp.907-922, 1977.

N. P. Brodin, M. Af-rosenschöld, P. Aznar, M. C. Kiil-berthelsen, A. Vogelius et al., Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma, Acta Oncol, vol.50, pp.806-822, 2011.

R. Miralbell, A. Lomax, L. Cella, and U. Schneider, Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors, Int J Radiat Oncol Biol Phys, vol.54, pp.824-833, 2002.

B. S. Athar and H. Paganetti, Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans, Radiother Oncol, vol.98, pp.87-92, 2011.

I. Kristensen, K. Nilsson, and P. Nilsson, Comparative proton and photon treatment planning in pediatric patients with various diagnoses, Int J Part Ther, vol.2, pp.367-75, 2015.

K. S. Armoogum and N. Thorp, Dosimetric Comparison and potential for improved clinical outcomes of paediatric CNS patients treated with protons or IMRT. Cancers (Basel), vol.7, pp.706-728, 2015.

D. Takizawa, M. Mizumoto, T. Yamamoto, Y. Oshiro, H. Fukushima et al., A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors, Radiat Oncol, vol.12, p.40, 2017.

M. Sato, J. R. Gunther, A. Mahajan, J. E. Paulino, A. C. Adesina et al., Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy, vol.123, pp.2570-2578, 2017.

S. M. Macdonald, S. Safai, A. Trofimov, J. Wolfgang, B. Fullerton et al., Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons, Int J Radiat Oncol Biol Phys, vol.71, pp.979-86, 2008.

M. Donald, S. M. Sethi, R. Lavally, B. Yeap, B. Y. Marcus et al., Proton radiotherapy for pediatric central nervous system ependymoma: Clinical outcomes for 70 patients, Neuro Oncol, vol.15, pp.1552-1561, 2013.

M. B. Pulsifer, R. Sethi, K. A. Kuhlthau, S. M. Macdonald, N. J. Tarbell et al., Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors, Int J Radiat Oncol Biol Phys, vol.93, pp.400-407, 2015.

A. Ducassou, L. Padovani, L. Chaltiel, S. Bolle, J. Habrand et al., Pediatric localized intra cranial ependymomas: a multicenter analysis of the children's cancer french society (SFCE), Int J Radiat Oncol, vol.102, pp.2364-2373, 2017.

F. Tensaouti, A. Ducassou, L. Chaltiel, S. Bolle, X. Muracciole et al., Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma, Radiother Oncol, vol.122, pp.362-369, 2017.

F. Tensaouti, A. Ducassou, L. Chaltiel, A. Sevely, S. Bolle et al., Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma, Radiother Oncol, vol.127, pp.103-110, 2018.

M. Massimino, R. Miceli, F. Giangaspero, L. Boschetti, P. Modena et al., Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma, Neuro Oncol, vol.18, pp.1451-60, 2016.

, Prescribing, recording, and reporting photon-beam intensitymodulated radiation therapy (IMRT): contents, J ICRU, p.10, 2010.

M. Van-veelen-vincent, A. Pierre-kahn, C. Kalifa, C. Sainte-rose, M. Zerah et al., Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy, J Neurosurg, vol.97, pp.827-862, 2002.

D. Figarella-branger, M. Civatte, C. Bouvier-labit, J. Gouvernet, D. Gambarelli et al., Prognostic factors in intracranial ependymomas in children, J Neurosurg, vol.93, pp.605-618, 2000.

H. Witt, S. C. Mack, M. Ryzhova, S. Bender, M. Sill et al., Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma, Cancer Cell. NIH, vol.20, pp.143-57, 2011.

N. D. Sabin, T. E. Merchant, X. Li, Y. Li, P. Klimo et al., Quantitative imaging analysis of posterior fossa ependymoma location in children, Childs Nerv Syst, vol.32, pp.1441-1448, 2016.

B. Rombi, S. Vennarini, L. Vinante, D. Ravanelli, and M. Amichetti, Proton radiotherapy for pediatric tumors: review of first clinical results, Ital J Pediatr, vol.40, p.74, 2014.

S. Ken, L. Vieillevigne, X. Franceries, L. Simon, C. Supper et al., Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost, Radiat Oncol, vol.8, p.1, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00780170

A. D. Rao, A. S. Rashid, Q. Chen, R. C. Villar, D. Kobyzeva et al., Reirradiation for recurrent pediatric central nervous system malignancies: a multi-institutional review, Int J Radiat Oncol, vol.99, pp.634-675, 2017.

B. R. Eaton, V. Chowdhry, K. Weaver, L. Liu, D. Ebb et al., Use of proton therapy for re-irradiation in pediatric intracranial ependymoma, Radiother Oncol, vol.116, pp.301-309, 2015.

D. S. Tsang, E. Burghen, P. Klimo, F. A. Boop, D. W. Ellison et al., Outcomes after reirradiation for recurrent pediatric intracranial ependymoma, Int J Radiat Oncol, vol.100, pp.507-522, 2018.

E. Régnier, A. Laprie, A. Ducassou, S. Bolle, S. Supiot et al., Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children's cancer, Radiother Oncol, vol.132, pp.1-7, 2019.

B. Rombi, C. Ares, E. B. Hug, R. Schneider, G. Goitein et al., Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: Clinical outcome of 26 patients treated at paul scherrer institute, Int J Radiat Oncol Biol Phys, vol.86, pp.578-84, 2013.

V. Fung, V. Calugaru, S. Bolle, H. Mammar, C. Alapetite et al., Proton beam therapy for skull base chordomas in 106 patients: a dose adaptive radiation protocol, Radiother Oncol, vol.128, pp.198-202, 2018.

V. Verma, J. Rwigema, R. S. Malyapa, W. F. Regine, and C. B. Simone, Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation, Radiother Oncol, vol.125, pp.21-30, 2017.

T. E. Merchant, R. M. Chitti, C. Li, X. Xiong, R. A. Sanford et al., Factors associated with neurological recovery of brainstem function following postoperative conformal radiation therapy for infratentorial ependymoma, Int J Radiat Oncol Biol Phys, vol.76, pp.496-503, 2010.

D. J. Indelicato, S. Flampouri, R. L. Rotondo, J. A. Bradley, C. G. Morris et al., Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy, Acta Oncol (Madr), vol.53, pp.1298-304, 2014.

D. Haas-kogan, D. Indelicato, H. Paganetti, N. Esiashvili, A. Mahajan et al., National cancer institute workshop on proton therapy for children: considerations regarding brainstem injury, Int J Radiat Oncol, vol.101, pp.152-68, 2018.

S. M. Macdonald, N. N. Laack, and S. Terezakis, Humbling advances in technology: protons, brainstem necrosis, and the self-driving car, Int J Radiat Oncol Biol Phys, vol.97, pp.216-225, 2017.

F. Tensaouti, A. Ducassou, L. Chaltiel, A. Sevely, S. Bolle et al., Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study, Br J Radiol, vol.89, 2016.

K. W. Pajtler, H. Witt, M. Sill, D. Jones, V. Hovestadt et al., Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups, Cancer Cell, vol.27, pp.728-771, 2015.

R. Mohan, I. J. Das, and C. C. Ling, Empowering intensity modulated proton therapy through physics and technology: an overview, Int J Radiat Oncol, vol.99, pp.304-320, 2017.

M. M. Ladra, S. M. Macdonald, and S. A. Terezakis, Proton therapy for central nervous system tumors in children, Pediatr Blood Cancer, vol.65, p.27046, 2018.

C. R. Peeler, D. Mirkovic, U. Titt, P. Blanchard, J. R. Gunther et al., Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma, Radiother Oncol, vol.121, pp.395-401, 2016.

A. Carabe, S. España, C. Grassberger, and H. Paganetti, Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver, Phys Med Biol, vol.58, pp.2103-2120, 2013.

M. C. Frese, J. J. Wilkens, P. E. Huber, A. D. Jensen, U. Oelfke et al., Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy, Int J Radiat Oncol Biol Phys, vol.79, pp.80-88, 2011.

G. Giovannini, T. Böhlen, G. Cabal, J. Bauer, T. Tessonnier et al., Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios, Radiat Oncol, vol.11, p.68, 2016.

N. Tilly, J. Johansson, U. Isacsson, J. Medin, E. Blomquist et al., The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer, Phys Med Biol, vol.50, pp.2765-77, 2005.

T. Underwood, D. Giantsoudi, M. Moteabbed, A. Zietman, J. Efstathiou et al., Can we advance proton therapy for prostate? considering alternative beam angles and relative biological effectiveness variations when comparing against intensity modulated radiation therapy, Int J Radiat Oncol Biol Phys, vol.95, pp.454-64, 2016.

D. Giantsoudi, C. Grassberger, D. Craft, A. Niemierko, A. Trofimov et al., Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential, Int J Radiat Oncol Biol Phys, vol.87, pp.216-238, 2013.

Q. Cheng, E. Roelofs, B. Ramaekers, D. Eekers, J. Van-soest et al., Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer-Comparison of dose, toxicity, and cost-effectiveness, Radiother Oncol, vol.118, pp.281-286, 2016.

J. A. Langendijk, P. Lambin, D. Ruysscher, D. Widder, J. Bos et al., Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach, Radiother Oncol, vol.107, pp.267-73, 2013.

M. Hoogeman, T. Arts, S. Van-de-water, S. Der-voort, Z. Perkó et al., SP-0010: Selection of patients for proton therapy: a physicists view, Radiother Oncol, vol.119, issue.16, pp.31259-31261, 2016.

E. Venema, C. Timmermans, J. Penninkhof, S. Petit, and B. Heijmen, SP-0666: Automated treatment planning-from theory to practice, Radiother Oncol, vol.127, issue.18, pp.30976-30985, 2018.